Cargando…

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic inflammatory disease that has been known since the early 1990s. Swallowed topical corticosteroids (STC) belong to the therapeutic cornerstones. We describe a delayed hypersensitivity reaction to Jorveza®, a newly developed orodispersible budeso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrist, Caroline Michèle, Jörg, Lukas, Greuter, Thomas, Gschwend, Anna, Straumann, Alex, Helbling, Arthur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731540/ https://www.ncbi.nlm.nih.gov/pubmed/33308158 http://dx.doi.org/10.1186/s12876-020-01554-y

Ejemplares similares

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence
por: Miehlke, Stephan, et al.
Publicado: (2020)

Oral Hairy Leukoplakia Related to Orodispersible Budesonide Use
por: McNeice, Andrew, et al.
Publicado: (2020)

Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme
por: Miehlke, Stephan, et al.
Publicado: (2022)

Eosinophilic esophagitis—established facts and new horizons
por: Biedermann, Luc, et al.
Publicado: (2021)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
por: Casiraghi, Antonella, et al.
Publicado: (2020)

Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis
por: Gupta, Sandeep K., et al.
Publicado: (2022)

Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis—Current Concepts and Perspectives for Steroid Use
por: Greuter, Thomas, et al.
Publicado: (2018)

Flare-up reactions in severe drug hypersensitivity: infection or ongoing T-cell hyperresponsiveness
por: Jörg-Walther, Lukas, et al.
Publicado: (2015)

Eosinophilic cholangitis treatment with budesonide
por: De Roza, Marianne Anastasia, et al.
Publicado: (2017)

A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide
por: Liu, Xiaopei, et al.
Publicado: (2022)

A Case of Eosinophilic Esophagitis With Food Hypersensitivity
por: Kim, Nam In, et al.
Publicado: (2010)

Is There a Role for Topical Swallowed Steroids upon Emergency Room Admission for Suspected Food Bolus Obstruction in Eosinophilic Esophagitis?
por: Schreiner, Philipp, et al.
Publicado: (2021)

Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis
por: Ahmet, Alexandra, et al.
Publicado: (2016)

Current concepts in eosinophilic esophagitis
por: Simon, Dagmar, et al.
Publicado: (2017)

Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension
por: Hudgens, Stacie, et al.
Publicado: (2017)

Treatment with IL5-/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Gschwend, Anna, et al.
Publicado: (2022)

Induction of Eosinophilic Esophagitis by Sublingual Pollen Immunotherapy
por: Miehlke, Stephan, et al.
Publicado: (2013)

A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis
por: Oliva, Salvatore, et al.
Publicado: (2019)

Comment on Casiraghi et al. “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis” 2020, 12, 211
por: Zur, Eyal
Publicado: (2020)

Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis
por: Numan, Laith, et al.
Publicado: (2023)

Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis
por: Mukkada, Vincent A., et al.
Publicado: (2023)

In Vitro Effects of Budesonide on Eosinophil-Basophil Lineage Commitment
por: Cyr, Michael M, et al.
Publicado: (2008)

Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
por: Casiraghi, Antonella, et al.
Publicado: (2020)

A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature
por: Warzecha, Joanna, et al.
Publicado: (2022)

75% negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics: Influencing factors and interpretation of test results
por: Joerg, Lukas, et al.
Publicado: (2021)

Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies
por: Rawla, Prashanth, et al.
Publicado: (2018)

Concept of Orodispersible or Mucoadhesive “Tandem Films” and Their Pharmaceutical Realization
por: Göbel, Anja, et al.
Publicado: (2022)

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis
por: Miehlke, Stephan, et al.
Publicado: (2016)

Acute Herpes Simplex Viral Esophagitis Occurring in 5 Immunocompetent Individuals With Eosinophilic Esophagitis
por: Zimmermann, Dorothee, et al.
Publicado: (2016)

Eosinophilic Gastroenteritis-associated Duodenal Ulcer Successfully Treated with Crushed Budesonide
por: Kubo, Kimitoshi, et al.
Publicado: (2020)

IMMUNOLOGICAL SPECIFICITY OF DELAYED AND IMMEDIATE HYPERSENSITIVITY REACTIONS
por: Benacerraf, B., et al.
Publicado: (1962)

Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Jörg, Lukas, et al.
Publicado: (2020)

Development of a Taste-Masked Orodispersible Film Containing Dimenhydrinate
por: Preis, Maren, et al.
Publicado: (2012)

Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis
por: Bon, Lorenz, et al.
Publicado: (2022)

Eosinophilic gastroenteritis with gastric and small bowel involvement: successful treatment with oral budesonide
por: Alsayegh, Mohammad, et al.
Publicado: (2012)

Delayed Cutaneous Hypersensitivity Reactions in Patients With Kaposi's Sarcoma
por: Taylor, J. F., et al.
Publicado: (1974)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

Esophageal Crohn's Disease Treated “Topically” with Swallowed Aerosolized Budesonide
por: Zezos, Petros, et al.
Publicado: (2010)

Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross‐sectional multi‐center study
por: Greuter, Thomas, et al.
Publicado: (2022)

STUDIES ON DELAYED HYPERSENSITIVITY : I. INFERENCES ON THE COMPARATIVE BINDING AFFINITIES OF ANTIBODIES MEDIATING DELAYED AND IMMEDIATE HYPERSENSITIVITY REACTIONS IN THE GUINEA PIG
por: Levine, Bernard B.
Publicado: (1965)

Cannot write session to /tmp/vufind_sessions/sess_u9a5gdu01t9h16l5o53ovebrmq